HUMA CIK: 1818382

Humacyte, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
1.26
FY22:
1.57
FY23:
0
FY24:
0
FY25:
−7.66
(positive)
Change from FY21 to FY25
millions USD
FY21:
−81.2
FY22:
−84.6
FY23:
−100
FY24:
−114
FY25:
−108
(positive)
Change from FY21 to FY25
millions USD
FY21:
−73.0
FY22:
−73.7
FY23:
–
FY24:
−103
FY25:
−98.2
(positive)
Change from FY21 to FY25
millions USD
FY21:
−26.5
FY22:
−12.0
FY23:
–
FY24:
−149
FY25:
−40.8
(positive)
Change from FY21 to FY25
millions USD
FY21:
−26.5
FY22:
−12.0
FY23:
−111
FY24:
−149
FY25:
−40.8

All amounts in millions USD Data sources:SEC EDGARTwelve Data